In vivo CAR T-cell engineering represents a fundamental rethinking of how cellular therapies are produced and delivered. Chimeric antigen receptor (CAR) T-cell therapy has fundamentally reshaped the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results